IRCT2014011015509N1已完成未知
Comparison of 5% dapsone gel plus oral isotretinoin with oral isotretinoin alone in young patients with moderate to severe facial acne
Vice Chancellor for Research, Isfahan University of Medical Sciences0 个研究点目标入组 58 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 58
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 25 years（—）
- 性别
- All
入选标准
- •age between 18 and 25 years old; moderate to severe facial acne; absence of contraindications to treatment with tablets of isotretinoin and 5% dapsone gel.
- •Exclusion criteria: acne secondary to other problems; pregnancy or intention to become pregnant; breastfeeding; another dermatological disease of the face; G6PD deficiency; and known hypersensitivity to dapsone or isotretinoin.
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Dapson in acne vulgarisIRCT2017072035195N1Rasht University of Medical Sciences60
已完成
4 期
Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne VulgarisAcne VulgarisNCT00835198Allergan163
招募中
3 期
Effect of Dapsone gel 5% in the treatment of patients with acne vulgarisIRCT20230806059062N1Ahvaz University of Medical Sciences60
已完成
不适用
Dapsone gel in the treatment of papulopustular rosaceaPapulopustular Rosacea.Other rosaceaIRCT2014010516079N1Vice chancellor for research, Isfahan University of Medical Sciences56
已完成
4 期
Dapsone Gel 5% and Tazarotene Cream 0.1% Versus Tazarotene Cream 0.1% Monotherapy for Facial Acne VulgarisAcne VulgarisNCT00834210Allergan171